2 ‘hidden’ AI stocks in the FTSE 100

Here are two Footsie companies that are set to benefit from the rise of artificial intelligence yet aren’t generally considered AI stocks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Man thinking about artificial intelligence investing algorithms

Image source: Getty Images.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

The shares of companies directly associated with artificial intelligence (AI) have soared in 2023. Meta, Nvidia and Tesla have all notched triple-digit gains this year. Meanwhile, many smaller AI stocks have also risen dramatically.

Here, I’m going to look at two FTSE 100 companies that don’t often get associated with AI, but which are already harnessing the technology in powerful ways.

Ocado

First up is Ocado (LSE: OCDO), the online grocer that also builds automated warehouses for large supermarkets around the world.

Should you invest £1,000 in AstraZeneca right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?

See the 6 stocks

Now, I’ll admit that when I see those purple Ocado delivery vans driving about, I don’t immediately think of cutting-edge technology. But the assembly of those grocery orders rests on robotics, artificial intelligence, machine learning, and data science.

As Ocado puts it: “We use AI to make possible in seconds what even many thousands of humans working together can’t.” It specifically uses the technology to manage stock levels and limit food waste.

Plus, its armies of warehouse robots pick the correct grocery orders thanks to an AI-powered ‘air traffic control’ system. This makes hundreds of decisions a second, directing the ‘swarm’ of bots around a 3D grid like a giant game of Tetris.

The result, according to the company, is that a 50-item order is picked in five minutes compared to an hour by a human in a store.

Finally, those delivery vans might be due a futuristic upgrade soon. That’s because Ocado, in partnership with London-based tech firm Wayve, is currently trialling driverless delivery vehicles across London.

These self-driving vehicles use camera technology and artificial intelligence to navigate congested city streets.

Created with Highcharts 11.4.3Ocado Group Plc PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

After rising 79%, Ocado is the FTSE 100’s top-performing stock over the last three months. However, over a three-year period, the shares are down nearly 60%.

While the company is still losing money, which certainly adds risk, I’m going to invest in the stock this month.

AstraZeneca

When thinking of AI, ‘big pharma’ companies like AstraZeneca (LSE: AZN) probably don’t instantly spring to mind.

Yet data is the fuel for AI, and the pharmaceutical industry is built around data (from research and development to clinical trials). And more data has been created in the past couple of years than in the entire history of humanity.

Currently, it takes more than a decade and typically costs between $1bn and $3bn to discover and make a new drug. Yet 90% of drugs fail in clinical trials. So the opportunity for AI to improve this statistic through superior drug discovery seems significant.

Already AstraZeneca is using sophisticated AI-based computer models to find the most promising molecules. This could get medicines to market much more quickly and cheaply.

Of course, if high-profile clinical trials don’t succeed, the share price can take a hit. This happened recently when AstraZeneca reported mixed results from its phase 3 trial for datopotamab deruxtecan, a potential new drug for lung cancer.

Created with Highcharts 11.4.3AstraZeneca Plc PriceZoom1M3M6MYTD1Y5Y10YALL7 Aug 20187 Aug 2023Zoom ▾Jan '19Jul '19Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '232019201920202020202120212022202220232023www.fool.co.uk

However, the firm has a huge pipeline of 178 projects across the areas of cancer, cardiovascular, kidney, and rare and respiratory diseases. This means it’s incredible well-diversified, with multiple shots at goal.

Plus, the stock is trading on a forward-looking price-to-earnings (P/E) ratio of 18, which I consider reasonable.

If I didn’t already have significant exposure to the healthcare space, I’d add AstraZeneca shares to my ISA today.

But what does the head of The Motley Fool’s investing team think?

Should you invest £1,000 in AstraZeneca right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Ben McPoland has positions in Nvidia and Tesla. The Motley Fool UK has recommended Meta Platforms, Nvidia, Ocado Group Plc, and Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

I think shares in this FTSE 100 company are undervalued right now

After a series of acquisitions, Informa’s balance sheet is loaded with goodwill. But is this hiding the true value of…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Here are the FTSE 100 shares that have outperformed the S&P 500 since 2020

A surprising number of FTSE 100 stocks have outperformed their S&P 500 counterparts over the last five years. But can…

Read more »

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Prediction: in 12 months the recovering Vodafone share price could turn £10,000 into…

Harvey Jones has been watching the Vodafone share price slide for so long that he can't come to terms with…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Down 35% with a 5% yield! Is this the cheapest dividend stock on the FTSE 250?

Mark Hartley considers the income potential of a FTSE 250 dividend stock that looks to be trading well below its…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

£10,000 invested in Lloyds shares 6 months ago is now worth…

Lloyds shares appear to be plateauing after surging beyond market expectations over the past year. Dr James Fox takes a…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

This old-school tech stock is beating all Magnificent 7 shares in 2025, including Nvidia

Shares in this old technology company are soaring in 2025, outperforming Nvidia stock and many other popular tech investments.

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Prediction: in 12 months the under-achieving Legal & General Group share price could turn £10k into…

Harvey Jones expected better from the Legal & General share price, but he has no complaints about the FTSE 100…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

See the latest BP share price and dividend forecasts

Harvey Jones examines the outlook for the BP share price after what's been a tough year. The yield's climbed nicely…

Read more »